<DOC>
	<DOCNO>NCT00870324</DOCNO>
	<brief_summary>The SENSE-AF study aim determine performance OptiSense lead sense fine episode Atrial Tachyarrhythmia/Atrial Fibrillation ( AT/AF ) reject Far-Field R Wave ( FFRW ) . The performance lead measure difference device-determined time AT/AF surface-ECG determine time AT/AF . This measurement compare control group randomize receive SJM 's Tendril™ RA lead .</brief_summary>
	<brief_title>OptiSense™ Performance Detecting Atrial Episodes</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients meet current ICD CRTD implant indication receive St. Jude Medical ICD/CRTD Patients receive new St. Jude Medical OptiSense Tendril RA lead part device implant Patients history Permanent Persistent AF Patient 's life expectancy le 12 month . Patient pregnant . Patient 's age enrollment le 18 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>ICD</keyword>
	<keyword>Tachyarrhythmias</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Patients meet current ICD CRT-D implant indication</keyword>
</DOC>